NR-565 ADVANCED PHARMACOLOGY
FUNDAMENTALS WEEK 4 MIDTERM PROCTORED
EXAM WITH QUESTIONS AND CORRECT ANSWERS
2026
1. A 68-year-old patient with reduced hepatic function is prescribed a drug primarily
metabolized by the CYP3A4 enzyme system. Which pharmacokinetic process is most
likely impaired in this patient? A. Absorption B. Distribution C. Metabolism D. Excretion
Correct Answer: C
Explanation: Metabolism (primarily hepatic via CYP450 enzymes like 3A4) is impaired in elderly
patients with reduced liver function, leading to higher drug levels and prolonged effects.
Absorption, distribution, and excretion may also be affected but are not the primary concern here.
2. Which of the following best describes the concept of pharmacodynamics? A. How the
body processes and eliminates a drug B. The biochemical and physiologic effects of
drugs on the body C. The rate at which a drug is absorbed into the bloodstream D.
Genetic variations affecting drug metabolism
Correct Answer: B Explanation: Pharmacodynamics refers to what the drug does to the body
(effects and mechanisms), while pharmacokinetics is what the body does to the drug.
3. During which trimester of pregnancy is the fetus at highest risk for major structural
malformations from teratogenic drugs? A. First trimester B. Second trimester C. Third
trimester D. Equally across all trimesters
Correct Answer: A Explanation: The first trimester involves organogenesis, making it the period
of highest risk for teratogenic effects. Later trimesters carry risks of functional or growth
impairments.
4. An NP is reviewing the BEERS Criteria before prescribing to a 78-year-old patient. The
criteria primarily help avoid: A. Drugs with high abuse potential B. Potentially
inappropriate medications in older adults C. Drugs that interact with CYP450 inducers D.
Medications requiring renal dose adjustment
Correct Answer: B Explanation: BEERS Criteria identifies medications that may be
inappropriate for adults 65+ due to high risk of adverse effects in the elderly.
, 5. A patient taking warfarin is prescribed a new medication known to be a potent CYP2C9
inhibitor. What is the most likely clinical outcome? A. Decreased warfarin levels leading
to thrombosis B. Increased warfarin levels leading to bleeding risk C. No significant
interaction D. Increased metabolism of both drugs
Correct Answer: B Explanation: CYP2C9 inhibition reduces warfarin metabolism, increasing its
anticoagulant effect and bleeding risk.
6. Which schedule of controlled substances has high potential for abuse but accepted
medical use with severe restrictions? A. Schedule I B. Schedule II C. Schedule III D.
Schedule IV
Correct Answer: B Explanation: Schedule II drugs (e.g., opioids like oxycodone) have high abuse
potential but accepted medical uses with strict controls.
7. A patient with heart failure is started on a beta-blocker. This drug primarily acts by: A.
Stimulating beta-1 receptors B. Blocking beta-adrenergic receptors C. Increasing
sympathetic outflow D. Inhibiting alpha-1 receptors
Correct Answer: B Explanation: Beta-blockers antagonize beta receptors, reducing heart rate
and contractility, beneficial in heart failure.
8. In a patient with chronic kidney disease (CrCl 25 mL/min), which pharmacokinetic
parameter requires the most careful consideration for renally cleared drugs? A. First-pass
effect B. Excretion C. Protein binding D. Volume of distribution
Correct Answer: B Explanation: Reduced renal function impairs excretion of drugs cleared by
the kidneys, necessitating dose adjustments.
9. Which of the following is an example of a CYP450 inducer? A. Ketoconazole B.
Rifampin C. Grapefruit juice D. Amiodarone
Correct Answer: B Explanation: Rifampin is a potent inducer that increases CYP450 enzyme
activity, accelerating metabolism of substrate drugs.
, 10. An elderly patient on multiple medications develops confusion after starting an
anticholinergic drug. This is most likely due to: A. Increased blood-brain barrier
permeability B. Age-related decrease in cholinergic function C. Enhanced renal clearance
D. First-pass metabolism changes
Correct Answer: B Explanation: Older adults have reduced cholinergic reserve, making them
more susceptible to anticholinergic side effects like confusion.
11. A patient is prescribed levothyroxine. The NP understands that monitoring should focus
on: A. TSH levels B. Serum potassium C. Liver enzymes D. Blood glucose
Correct Answer: A Explanation: TSH is the primary monitoring parameter for thyroid hormone
replacement therapy efficacy and dosing.
12. Which statement regarding pharmacogenomics is correct? A. It has no role in
individualized drug therapy B. It studies how genes affect a person's response to drugs C.
It only applies to antibiotics D. It focuses solely on drug metabolism rates
Correct Answer: B Explanation: Pharmacogenomics combines genomics and pharmacology for
personalized, targeted therapies.
13. A 55-year-old patient with hypertension is started on an ACE inhibitor. The NP should
monitor for: A. Hyperkalemia B. Hypokalemia C. Hyponatremia D. Hypernatremia
Correct Answer: A Explanation: ACE inhibitors can cause hyperkalemia by reducing
aldosterone-mediated potassium excretion.
14. The volume of distribution (Vd) is primarily affected by: A. Drug lipophilicity and
protein binding B. Renal clearance rate C. Hepatic enzyme activity D. GI pH
Correct Answer: A Explanation: Vd reflects how extensively a drug distributes into tissues,
influenced by lipid solubility and protein binding.
15. In a scenario involving opioid overdose, naloxone's primary mechanism is: A. Mu-
receptor agonist B. Mu-receptor competitive antagonist C. Kappa-receptor stimulator D.
Delta-receptor inhibitor
, Correct Answer: B Explanation: Naloxone is a competitive antagonist at mu-opioid receptors,
rapidly reversing opioid effects.
16. Which drug class requires caution in patients with sulfa allergy? A. Beta-blockers B.
Loop diuretics (e.g., furosemide) C. ARBs D. Calcium channel blockers
Correct Answer: B Explanation: Some loop diuretics like furosemide have sulfa moieties,
potentially causing cross-reactivity.
17. Half-life (t½) determines: A. How quickly a drug reaches steady state B. The time for
plasma concentration to reduce by 50% C. The absorption rate D. Protein binding affinity
Correct Answer: B Explanation: Half-life is the time required for the plasma concentration of a
drug to decrease by 50%.
18. A pregnant patient in the third trimester requires pain management. Which consideration
is most important? A. Risk of premature closure of ductus arteriosus with NSAIDs B. No
drug restrictions apply C. Only Schedule I drugs are safe D. Increased first-pass effect
Correct Answer: A Explanation: NSAIDs in late pregnancy can cause premature closure of the
fetal ductus arteriosus.
19. The NP prescribes a statin to a patient. The primary site of action is: A. HMG-CoA
reductase in the liver B. ACE enzyme in the lungs C. Beta-2 receptors in the lungs D.
Calcium channels in vascular smooth muscle
Correct Answer: A Explanation: Statins inhibit HMG-CoA reductase, the rate-limiting enzyme
in cholesterol synthesis in the liver.
20. Which of the following is a narrow therapeutic index drug requiring close monitoring? A.
Amoxicillin B. Digoxin C. Lisinopril D. Metformin
Correct Answer: B Explanation: Digoxin has a narrow therapeutic index; small changes in levels
can lead to toxicity or subtherapeutic effects.
FUNDAMENTALS WEEK 4 MIDTERM PROCTORED
EXAM WITH QUESTIONS AND CORRECT ANSWERS
2026
1. A 68-year-old patient with reduced hepatic function is prescribed a drug primarily
metabolized by the CYP3A4 enzyme system. Which pharmacokinetic process is most
likely impaired in this patient? A. Absorption B. Distribution C. Metabolism D. Excretion
Correct Answer: C
Explanation: Metabolism (primarily hepatic via CYP450 enzymes like 3A4) is impaired in elderly
patients with reduced liver function, leading to higher drug levels and prolonged effects.
Absorption, distribution, and excretion may also be affected but are not the primary concern here.
2. Which of the following best describes the concept of pharmacodynamics? A. How the
body processes and eliminates a drug B. The biochemical and physiologic effects of
drugs on the body C. The rate at which a drug is absorbed into the bloodstream D.
Genetic variations affecting drug metabolism
Correct Answer: B Explanation: Pharmacodynamics refers to what the drug does to the body
(effects and mechanisms), while pharmacokinetics is what the body does to the drug.
3. During which trimester of pregnancy is the fetus at highest risk for major structural
malformations from teratogenic drugs? A. First trimester B. Second trimester C. Third
trimester D. Equally across all trimesters
Correct Answer: A Explanation: The first trimester involves organogenesis, making it the period
of highest risk for teratogenic effects. Later trimesters carry risks of functional or growth
impairments.
4. An NP is reviewing the BEERS Criteria before prescribing to a 78-year-old patient. The
criteria primarily help avoid: A. Drugs with high abuse potential B. Potentially
inappropriate medications in older adults C. Drugs that interact with CYP450 inducers D.
Medications requiring renal dose adjustment
Correct Answer: B Explanation: BEERS Criteria identifies medications that may be
inappropriate for adults 65+ due to high risk of adverse effects in the elderly.
, 5. A patient taking warfarin is prescribed a new medication known to be a potent CYP2C9
inhibitor. What is the most likely clinical outcome? A. Decreased warfarin levels leading
to thrombosis B. Increased warfarin levels leading to bleeding risk C. No significant
interaction D. Increased metabolism of both drugs
Correct Answer: B Explanation: CYP2C9 inhibition reduces warfarin metabolism, increasing its
anticoagulant effect and bleeding risk.
6. Which schedule of controlled substances has high potential for abuse but accepted
medical use with severe restrictions? A. Schedule I B. Schedule II C. Schedule III D.
Schedule IV
Correct Answer: B Explanation: Schedule II drugs (e.g., opioids like oxycodone) have high abuse
potential but accepted medical uses with strict controls.
7. A patient with heart failure is started on a beta-blocker. This drug primarily acts by: A.
Stimulating beta-1 receptors B. Blocking beta-adrenergic receptors C. Increasing
sympathetic outflow D. Inhibiting alpha-1 receptors
Correct Answer: B Explanation: Beta-blockers antagonize beta receptors, reducing heart rate
and contractility, beneficial in heart failure.
8. In a patient with chronic kidney disease (CrCl 25 mL/min), which pharmacokinetic
parameter requires the most careful consideration for renally cleared drugs? A. First-pass
effect B. Excretion C. Protein binding D. Volume of distribution
Correct Answer: B Explanation: Reduced renal function impairs excretion of drugs cleared by
the kidneys, necessitating dose adjustments.
9. Which of the following is an example of a CYP450 inducer? A. Ketoconazole B.
Rifampin C. Grapefruit juice D. Amiodarone
Correct Answer: B Explanation: Rifampin is a potent inducer that increases CYP450 enzyme
activity, accelerating metabolism of substrate drugs.
, 10. An elderly patient on multiple medications develops confusion after starting an
anticholinergic drug. This is most likely due to: A. Increased blood-brain barrier
permeability B. Age-related decrease in cholinergic function C. Enhanced renal clearance
D. First-pass metabolism changes
Correct Answer: B Explanation: Older adults have reduced cholinergic reserve, making them
more susceptible to anticholinergic side effects like confusion.
11. A patient is prescribed levothyroxine. The NP understands that monitoring should focus
on: A. TSH levels B. Serum potassium C. Liver enzymes D. Blood glucose
Correct Answer: A Explanation: TSH is the primary monitoring parameter for thyroid hormone
replacement therapy efficacy and dosing.
12. Which statement regarding pharmacogenomics is correct? A. It has no role in
individualized drug therapy B. It studies how genes affect a person's response to drugs C.
It only applies to antibiotics D. It focuses solely on drug metabolism rates
Correct Answer: B Explanation: Pharmacogenomics combines genomics and pharmacology for
personalized, targeted therapies.
13. A 55-year-old patient with hypertension is started on an ACE inhibitor. The NP should
monitor for: A. Hyperkalemia B. Hypokalemia C. Hyponatremia D. Hypernatremia
Correct Answer: A Explanation: ACE inhibitors can cause hyperkalemia by reducing
aldosterone-mediated potassium excretion.
14. The volume of distribution (Vd) is primarily affected by: A. Drug lipophilicity and
protein binding B. Renal clearance rate C. Hepatic enzyme activity D. GI pH
Correct Answer: A Explanation: Vd reflects how extensively a drug distributes into tissues,
influenced by lipid solubility and protein binding.
15. In a scenario involving opioid overdose, naloxone's primary mechanism is: A. Mu-
receptor agonist B. Mu-receptor competitive antagonist C. Kappa-receptor stimulator D.
Delta-receptor inhibitor
, Correct Answer: B Explanation: Naloxone is a competitive antagonist at mu-opioid receptors,
rapidly reversing opioid effects.
16. Which drug class requires caution in patients with sulfa allergy? A. Beta-blockers B.
Loop diuretics (e.g., furosemide) C. ARBs D. Calcium channel blockers
Correct Answer: B Explanation: Some loop diuretics like furosemide have sulfa moieties,
potentially causing cross-reactivity.
17. Half-life (t½) determines: A. How quickly a drug reaches steady state B. The time for
plasma concentration to reduce by 50% C. The absorption rate D. Protein binding affinity
Correct Answer: B Explanation: Half-life is the time required for the plasma concentration of a
drug to decrease by 50%.
18. A pregnant patient in the third trimester requires pain management. Which consideration
is most important? A. Risk of premature closure of ductus arteriosus with NSAIDs B. No
drug restrictions apply C. Only Schedule I drugs are safe D. Increased first-pass effect
Correct Answer: A Explanation: NSAIDs in late pregnancy can cause premature closure of the
fetal ductus arteriosus.
19. The NP prescribes a statin to a patient. The primary site of action is: A. HMG-CoA
reductase in the liver B. ACE enzyme in the lungs C. Beta-2 receptors in the lungs D.
Calcium channels in vascular smooth muscle
Correct Answer: A Explanation: Statins inhibit HMG-CoA reductase, the rate-limiting enzyme
in cholesterol synthesis in the liver.
20. Which of the following is a narrow therapeutic index drug requiring close monitoring? A.
Amoxicillin B. Digoxin C. Lisinopril D. Metformin
Correct Answer: B Explanation: Digoxin has a narrow therapeutic index; small changes in levels
can lead to toxicity or subtherapeutic effects.
